Author: Pasquato, Antonella; Cendron, Laura; Kunz, Stefan
Title: Cleavage of the Glycoprotein of Arenaviruses Cord-id: 8zpfuqp1 Document date: 2018_2_16
ID: 8zpfuqp1
Snippet: The arenaviruses are a large family of emerging negative-stranded RNA viruses that include several severe human pathogens causing hemorrhagic fevers with high mortality. During the arenavirus life cycle, processing of the viral envelope glycoprotein precursor (GPC) by the cellular subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P) is crucial for productive infection. The ability of newly emerging arenaviruses to hijack human SKI-1/S1P is a key factor for zoonotic transmission and human dis
Document: The arenaviruses are a large family of emerging negative-stranded RNA viruses that include several severe human pathogens causing hemorrhagic fevers with high mortality. During the arenavirus life cycle, processing of the viral envelope glycoprotein precursor (GPC) by the cellular subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P) is crucial for productive infection. The ability of newly emerging arenaviruses to hijack human SKI-1/S1P is a key factor for zoonotic transmission and human disease potential. Apart from being an essential host factor for arenavirus infection, SKI-1/S1P is involved in the regulation of important physiological processes and linked to major human diseases. This chapter provides an overview of the mechanisms of arenavirus GPC processing by SKI-1/S1P including recent findings. We will highlight to what extent the molecular mechanisms of SKI-1/S1P cleavage of viral GPC differ from processing of SKI-1/S1P’s cellular substrates and discuss the implications for virus-host interaction and coevolution. Moreover, we will show how the use of the viral GPC as a “molecular probe†uncovered novel and unusual aspects of SKI-1/S1P biosynthesis and maturation. The crucial role of SKI-1/S1P in arenavirus infection and other major human diseases combined with its nature as an enzyme makes SKI-1/S1P further an attractive target for therapeutic intervention. In the last part, we will therefore cover past and present efforts to identify specific SKI-1/S1P inhibitors.
Search related documents:
Co phrase search for related documents- active enzyme and low micromolar range: 1
- active form and acute disease: 1, 2, 3
- active form and adhesion molecule: 1
- acute disease and additive effect: 1, 2
- acute disease and adhesion molecule: 1, 2, 3, 4, 5, 6, 7, 8, 9
- acute disease and low cytotoxicity: 1
- acute disease cause and adhesion molecule: 1
- additive effect and adhesion molecule: 1
- additive effect and low cytotoxicity: 1
- additive effect and low micromolar range: 1
Co phrase search for related documents, hyperlinks ordered by date